IGI Logo

Lyka Labs is currently trading at Rs. 138.15, up by 4.70 points or 3.52% from its previous closing of Rs. 133.45 on the BSE.

The scrip opened at Rs. 136.65 and has touched a high and low of Rs. 139.90 and Rs. 135.85 respectively. So far 3286 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 267.20 on 24-Dec-2021 and a 52 week low of Rs. 102.50 on 21-Jun-2022.

Last one week high and low of the scrip stood at Rs. 139.90 and Rs. 127.20 respectively. The current market cap of the company is Rs. 382.87 crore.

The promoters holding in the company stood at 47.59%, while Institutions and Non-Institutions held 4.57% and 47.84% respectively.

Lyka Labs has finalised and signed the agreement with Agilis Healthcare to acquire animal healthcare business. The cost of acquisition is up to Rs 3.5 crore. Agilis Healthcare is a Mumbai based company, incorporated in 2017. The company is in the business of animal healthcare, having 50+ employees. The company is marketing veterinary medicines and feed supplement products in India

Lyka Labs is engaged in the business of pharmaceutical and related activities, including research.